
Bradley R. Corr, MD, discusses a phase 2 study evaluating rucaparib maintenance therapy in patients with metastatic and recurrent endometrial cancer.

Your AI-Trained Oncology Knowledge Connection!


Bradley R. Corr, MD, discusses a phase 2 study evaluating rucaparib maintenance therapy in patients with metastatic and recurrent endometrial cancer.

Bradley R. Corr, MD, discusses the utilization of molecular profiling in endometrial cancer.

Bradley Corr, MD, discusses the rationale to evaluate WNT pathway inhibition in gynecologic cancers.

Published: January 4th 2021 | Updated:

Published: January 26th 2022 | Updated: